![Stelios Papadopoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stelios Papadopoulos
Oprichter bij
EXELIXIS, INC.
Vermogen: 61 M $ op 31-05-2026
Profiel
Dr. Stelios Papadopoulos is voorzitter bij Eucrates Biomedical Acquisition Corp., voorzitter bij Regulus Therapeutics, Inc., voorzitter bij Biogen, Inc., voorzitter raad van toezicht bij Biogen GmbH, voorzitter en penningmeester bij Fondation Sant, voorzitter bij Exelixis, Inc. en adjunct-hoofddocent aan de universiteit van New York. Hij zetelt in de Raad van Bestuur van Biogen Idec, Inc. (North Carolina), Diacrin, Inc. (Delaware), National Marrow Donor Program en The BioExec Institute, Inc. Dr. Papadopoulos was voorheen werkzaam als Onafhankelijk Bestuurder bij BG Medicine, Inc., als Oprichter bij Cellzome Ltd., als Vice-Voorzitter bij Cowen & Co. LLC, voorzitter bij Anadys Pharmaceuticals, Inc., voorzitter bij Instrumentation Laboratory Co., voorzitter bij PaineWebber Development Corp., investeringsbankier bij PaineWebber, Inc., voorzitter bij Cellzome, Inc. en vice-voorzitter van de afdeling aandelenonderzoek bij Drexel Burnham Lambert, Inc. Hij was ook lid van de raad van bestuur van GenVec, Inc., SGX Pharmaceuticals, Inc., Biogen Idec New Ventures, Inc., Joule Unlimited Technologies, Inc. en Neuronyx, Inc. Hij behaalde zijn doctorale graad aan de New York University, een MBA aan de New York University en een doctorale graad aan de New York University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EXELIXIS, INC. 0,48% | 27-05-2026 | 1.197.595 ( 0,48% ) | 60 M $ | 31-05-2026 |
| 17-04-2026 | 217.578 ( 0,12% ) | 593 988 $ | 31-05-2026 |
Actieve functies van Stelios Papadopoulos
| Bedrijven | Functie | Begin |
|---|---|---|
| EXELIXIS, INC. | Oprichter | 15-11-1994 |
| OVID THERAPEUTICS INC. | Directeur/Bestuurslid | 03-03-2025 |
Epikast, Inc.
 Epikast, Inc. Packaged SoftwareTechnology Services Develops AI tools for biopharma and healthcare | Oprichter | - |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Directeur/Bestuurslid | - |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Directeur/Bestuurslid | - |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Bestuurslid | 01-07-2008 |
National Marrow Donor Program
 National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Provides treatments for those facing life-threatening blood cancers | Directeur/Bestuurslid | - |
Fondation Santé | Oprichter | 01-01-2000 |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Eerdere bekende functies van Stelios Papadopoulos
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Stelios Papadopoulos
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
51
Eerstegraads connecties
29
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 29 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Health Technology |
BG Medicine, Inc.
 BG Medicine, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and manufactures drugs | Health Technology |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Drexel Burnham Lambert, Inc.
 Drexel Burnham Lambert, Inc. Agricultural Commodities/MillingProcess Industries Manufactures chocolates and sugar candies. | Process Industries |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs and other pharmaceutical products | Health Technology |
Instrumentation Laboratory Co.
 Instrumentation Laboratory Co. Medical SpecialtiesHealth Technology Manufactures diagnostic products | Health Technology |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Duke University Medical Center
Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Fondation Santé | |
PaineWebber Development Corp. | |
National Marrow Donor Program
National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Provides treatments for those facing life-threatening blood cancers | Commercial Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Joule Unlimited Technologies, Inc.
 Joule Unlimited Technologies, Inc. Industrial SpecialtiesProcess Industries Produces renewable fuels, gases and chemicals | Process Industries |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Health Technology |
Cellzome, Inc.
 Cellzome, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-inflammation therapy | Health Technology |
The BioExec Institute, Inc.
The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Commercial Services |
Eucrates Biomedical Acquisition Corp.
 Eucrates Biomedical Acquisition Corp. Financial ConglomeratesFinance Operates as an blank check company | Finance |
Graviton Bioscience Corp.
 Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases | Health Technology |
Epikast, Inc.
Epikast, Inc. Packaged SoftwareTechnology Services Develops AI tools for biopharma and healthcare | Technology Services |
